MetaStat, Inc. announced the promotion of Jerome B. Zeldis from Vice Chairman to Chairman and the appointment of Douglas A. Hamilton, MetaStat's President and Chief Executive Officer, to its board of directors in connection with a restructuring of MetaStat's board. Dr. Zeldis is the Chief Medical Officer of Sorrento Therapeutics, Inc., and previously served as Chief Medical Officer of Celgene Corporation and Chief Executive Officer of Celgene Global Health until June 2016. Mr. Hamilton has been President and CEO of MetaStat since June 2015. Previously, Mr. Hamilton served as CFO for SEA Medical Systems and since 2007, Partner at New Biology Ventures, a life-sciences incubator accelerator and consulting firm.